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Abstract: Neurotoxicity induced in fish by domoic acid (DA) was assessed with respect to 
occurrence  of  neurotoxic  signs,  lethality,  and  histopathology  by  light  microscopy. 
Sparus aurata were exposed to a single dose of DA by intraperitoneal (i.p.) injection of  
0, 0.45, 0.9, and 9.0 mg DA kg
−1 bw. Mortality (66.67 ±  16.67%) was only observed in 
dose of 9.0 mg kg
−1 bw. Signs of neurological  toxicity were detected for the doses of  
0.9 and 9.0 mg DA kg
−1 bw. Furthermore, the mean concentrations (± SD) of DA detected 
by HPLC-UV in extracts of brain after exposure to 9.0 mg DA kg
−1 bw were 0.61 ±  0.01, 
0.96 ±  0.00, and 0.36 ±  0.01 mg DA kg
−1 tissue at 1, 2, and 4 hours. The lack of major 
permanent brain damage in S. aurata, and reversibility of neurotoxic signs, suggest that 
lower susceptibility to DA or neuronal recovery occurs in affected individuals. 
Keywords: domoic acid; amnesic shellfish poisoning; Pseudo-nitzschia; algal neurotoxin; 
Sparus aurata 
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1. Introduction 
Domoic acid (DA) is synthesized by marine algae, such as the red algae Chondria armata and 
species of the diatom genus Pseudo-nitzschia [1,2]. DA is an analogue of kainic acid (KA), which 
shows  excitotoxic  activity.  Both  DA  and  KA  are  structurally  similar  to  glutamate,  which  is  the 
predominant neurotransmitter in the central nervous system. This structural similarity allows DA and 
KA  to  bind  to  the  glutamate  receptor  [GluRs]  family,  inducing  neuroexcitatory  and  neurotoxic  
effects [3–5]. 
The first documented case of DA intoxication occurred in 1987, when at least four people died and 
over a hundred others suffered severe neurological and gastrointestinal disorders [6]. Since then, other 
DA intoxication events have been recorded in the marine community, resulting in mass mortalities of 
sea birds and sea lions [7–10]. DA has been recognized as a harmful food web-transferred phycotoxin 
to  humans, through the consumption of mussels  [11] and to  marine mammals  and birds, through 
planktivorous fish and krill [12,13]. Although neurotoxic effects that result from the consumption of 
DA have been described in mammals and birds, to date no field evidence of DA toxicity in fish has 
been  documented.  Nevertheless,  concentrations  of  39  ±   0.7  mg  DA  kg
−1  in  the  body  tissues  of 
anchovies (Engraulis mordax) have been found [8].  
Thus far, DA-induced neurotoxicity in fish is poorly understood and the majority of the available 
information  is  related  to  DA-induced  excitotoxicological  signs  that  appeared  following  the 
intraperitoneal  (i.p.)  injection  of  DA.  When  juvenile  leopard  sharks  (Triakis  semifasciata)  were 
injected intraperitoneally with doses that ranged from 9–27 mg DA kg
−1 body weight (bw), no signs of 
toxicity were observed [14]. In contrast, the i.p. injection of doses from 1–14 mg DA kg
−1 bw induced 
excitotoxicological  signs  and  death  in  anchovies  (E.  mordax)  [15].  Further  evidence  of  DA 
neurotoxicity in fish was also obtained after the i.p. injection of killifish (Fundulus heteroclitus) with 
5 mg  DA  kg
−1  bw,  which  led  to  behavioral  alterations  and  increased  the  neuronal  expression  of  
c-Fos  [16].  Similarly,  the  i.p.  injection  of  coho  salmon  (Oncorhynchus  kisutch)  with  doses  of 
6.3 ±  0.6 mg DA kg
−1 bw resulted in neurotoxic signs [17]. In addition, changes in metabolic activity 
in  the  brain  of  the  Atlantic  salmon  (Salmo  salar)  were  found  after  the  i.p.  injection  of  
6.0 mg DA kg
−1 bw [8].  
To  summarize,  in  the  literature  there  is  evidence  that  DA  neurotoxicity  susceptibility  in  fish, 
following intraperitoneal (i.p.) injection, varies within species. Therefore, the main objective of this 
study  was  to  evaluate  DA-induced  neurotoxicity  in  another  model,  the  gilthead  seabream 
Sparus aurata. This species is common in the Mediterranean Sea, present along the Eastern Atlantic 
coasts from Great Britain to Senegal, both in marine and brackish waters such as coastal lagoons and 
estuarine  areas,  and  feed  on  a  variety  of  prey,  such  as  shellfish,  that can  concentrate  DA  during 
Pseudo-nitzschia  blooms.  For  this  purpose,  DA-induced  neurotoxicity  was  assessed  by  analyzing 
mortality,  the  occurrence  of  neurotoxic  signs  and  histopathological  changes.  The  distribution  of 
glutamate receptors 5, 6, and 7 (GluR5, 6, 7) in the brain of S. aurata was also studied by microscopy. 
In addition, the relationship between the neurotoxic signs was observed and the areas of the brain in 
S. aurata  that  were  affected  by  DA  were  analyzed.  The  amount  of  DA  in  the  liver  and  brain  of 
S. aurata after exposure to DA was also evaluated.  Mar. Drugs 2010, 8  
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2. Materials and Methods 
2.1. Chemicals 
All  solvents  and  chemical  reagents  were  high  performance  liquid  chromatography  (HPLC)  or 
analytical  grade. Methanol  (Merck) and  acetonitrile (Pancreac) were  HPLC grade;  perchloric  acid 
(Pancreac) and formic acid (Prolabo) were analytical grade. DA (95% purity) was purchased from 
Sigma-Aldrich. Milli-Q water (Millipore Corporation) was used to prepare all solutions of the toxin. 
2.2. Fish maintenance 
Juvenile  seabream  (S.  aurata)  was  used  as  a  model  species  because  of  its  ability  to  yield 
reproducible behavior data under controlled conditions [19].  
S. aurata were supplied by a commercial fish farm (TIMAR Lda., Setubal, Portugal), where they 
were raised until they reached 10–15 g. Fish were kept at our laboratory for two months, during which 
time they were fed three times a week with a maintenance ration of 2–3% bw, before being used 
in experiments. 
S. aurata were acclimatized to the experimental conditions for 48 h in 150-L glass aquaria. Food 
was not provided during the acclimation phase or during the course of the experiment. Aeration was 
provided through plastic tips placed 2 cm above the bottom of the aquarium.  
2.3. Experimental design 
The  experiments  were  done  in  natural  seawater  (34  ±  0.7  ppm)  under  a  photoperiod  of 
12 h light:12 h dark at 17 ±  0.8 ° C. The amount of dissolved oxygen (68 ±  22%), pH (7.7 ±  0.1), and 
concentration of total ammonia (0.2 ±  0.1 mg L
−1) were monitored daily. All aquaria that contained 
test organisms were isolated with opaque plastic to reduce external stimuli, such as movement of the 
experimenter, vibration, or visual cues.  
A maximum of six fish per 36 L aquarium were used in the experiments, and, in order to account 
for the intergroup aquarium variability, there were always three aquaria per treatment and two controls. 
Controls were individuals not injected or injected with phosphate buffered saline (PBS). These were 
used in order to evaluate non-toxic changes in the fish caused by manipulation, induced stress, or the 
effects of PBS.  
DA was dissolved in PBS and the stock solution was kept at −20 ° C until the experimental solutions 
were prepared.  
All fish were anesthetized within two minutes by immersion in 2-phenoxyethanol (0.2 mL L
−1), 
before  being  weighed,  then  the  i.p.  injection  volume  was  calculated  in  order  to  obtain  the 
desired concentration. 
At the end of each experiment, the water from each aquarium was renewed. The experimental setup 
used to evaluate the effects of DA in the gilthead seabream is summarized in Table 1. Mar. Drugs 2010, 8  
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Table  1.  Experimental  setup  used  to  evaluate  the  effects  of  domoic  acid  (DA)  in  the 
gilthead seabream Sparus aurata, three replicates were used in each treatment. 
Experimental setup  Time (hours)  Number of fish 
per aquarium 
Examination of DA neurotoxicity 
Behavioral observations  0.5 and 2  6 
Mortality  24  6 
Light microscopy and immunohistochemistry  24  2 
DA analyses  1, 2, and 4  3 
The fish were handled in accordance with the guidelines for accommodation and care of animals 
from the European Convention for the Protection of Vertebrate Animals used for Experimental and 
Other Scientific Purposes. 
2.4. Examination of DA neurotoxicity  
Eighteen individuals were exposed to 0.0, 0.45, 0.9, or 9.0 mg DA kg
−1 bw or PBS by i.p. injection. 
We conducted different consecutive studies within a period of one month, testing different treatments 
at the same time, using the nominal above mentioned concentrations.  
DA-induced neurotoxicity was assessed by mortality and the occurrence of neurotoxic signs, such 
as swimming in a circle, in a spiral, or upside down. Digital videos were recorded for 20 minutes, 
starting 30 minutes and two hours after the exposure. Moreover, mortality was evaluated after 24 hours 
of exposure. Given that ≥50% mortality was detected in the fish injected with 9.0 mg DA kg
−1 bw, no 
higher doses of DA were used in the study. 
2.5. Light microscopy and immunohistochemistry 
Six individuals exposed to 0.0, 0.45, 0.9, or 9.0 mg DA kg
−1 bw or PBS were killed by an overdose 
of anesthetic after 24 hours of exposure. The brain, liver, stomach and duodenum were collected and 
fixed  in  formaldehyde  (4%).  These  tissues  were  processed  routinely  for  embedding  in  paraffin, 
sectioned at 4 μm, and stained with hematoxylin and eosin. Sections of the metencephalon (more 
specifically,  the  cerebellar  cortex),  diencephalon,  myelencephalon,  and  mesencephalon  from 
individuals  exposed  to  PBS  for  24  hours  were  mounted  on  slides,  treated  with 
3-aminopropyltriethoxysilane  (Sigma)  to  improve  adhesion  of  the  sections,  and  used  for 
immunohistochemical studies using a previously described method [14].  
A streptavidin-biotin-peroxidase immunohistochemistry kit (Histostain Plus; Zymed) was used to 
detect  binding  of  the  primary  antibody,  according  to  the  manufacturer’s  instructions  with  minor 
adaptations. After rinsing in distilled water and PBS, the peroxidase activity was visualized using 
0.05% 3,3-diaminobenzidine (DAB) in PBS and 0.03% H2O2, which gave a brown-colored product. 
After rinsing in tap water, the sections were mounted in DPX.  The primary monoclonal antibody 
MAB379, which recognizes an epitope common to GluR5, 6, and 7, was purchased from Chemicon 
International (Temecula). Negative controls were performed in which no primary antibody was added; 
mouse  brain  tissue  was  used  as  a  positive  control.  Positive  immunoreactivity  was  based  on  the 
appearance of dark orange staining, which corresponded to the deposition of DAB deposition, as Mar. Drugs 2010, 8  
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compared with the negative and positive controls, revealing the presence of a monoclonal antibody 
recognizing kainic acid-type glutamate receptors (GluR 5, 6, 7). More detailed information can also be 
found in the work of Pulido [20]. 
2.6. DA levels in brain and liver  
To  measure  DA  levels  in  the  brain  and  liver,  nine  individuals  were  exposed  to  PBS  or 
9.0 mg DA kg
−1 bw. After 1, 2, and 4 hours of exposure, the brain and liver of three of the individuals 
were removed as described above, weighed, and then lyophilized.  
DA was extracted from the reconstituted tissues of S. aurata [21] and proteins were extracted with 
perchloric acid using a previously described method [22]. Recovery experiments were carried out to 
evaluate the efficiency of the extraction method. For this purpose, brain and liver samples were spiked 
with 50 ng of DA. The mean recovery values were 80% for brain samples and 90% for liver, which 
indicated the presence of a matrix effect that affected these recovery values. The amount of DA in the 
tissues  was  determined  by  HPLC-UV  [21]  as  summarized  in  Table  2.  DA  concentrations  were 
quantified on the basis of standard curves that used external DA standards, after correction for the 
amount of recovery.  
Table 2. HPLC-UV conditions for the analysis of domoic acid. 
HPLC Instrument  PV-980 Jasco 
Column  Reversed Phase Phenomenex luna C18, 5 µm, 100A ODS3, 250 ×  4.6 mm 
Mobile Phase  Acetonitrile:Water 12% (v/v) with formic acid 0.2% (v/v) 
Flow rate  1 mL min
−1 
UV detector  Jasco UV-1575 
Wavelength  242 nm 
Injection Volume  20 µL 
Data Analysis  Borwin software 
3. Results 
3.1. DA neurotoxicity  
The mortality of S. aurata (n = 18) after i.p. injection with 9.0 mg DA kg
−1 bw was 66.7 ±  16.7% 
(mean ±  SD). Under these conditions, 50% of mortality occurred at 7.1 hours after  exposure. No 
mortality was observed in the controls or after exposure to the other concentrations of DA. 
No signs of toxicity were observed in the controls. In some individuals exposed to 0.45 mg DA kg
−1 bw, 
some disturbances in behavior, characterized by vertical swimming, i.e., ascending and descending in 
the water column, were observed. The remaining individuals continued to show gregarious behavior, 
with  the  fish  remaining  in  the  centre  of  the  water  column  or  near  the  bottom  of  the  aquarium. 
Similarly,  in  some  individuals  exposed  to  0.9  mg  DA  kg
−1  bw,  disturbances  in  behavior  were 
observed. However, for this treatment, the disturbances  corresponded to  neurotoxic signs, such as 
swimming in a circle, in a spiral, or upside down. The observed disturbances in behavior were reversed 
after  4–5  hours  of  exposure  for  the  0.45  mg  DA  kg
−1  bw  dose  and  after  12  hours  for  the  
0.9 mg DA kg
−1 bw dose. In contrast, neurotoxic signs were observed in all individuals exposed to Mar. Drugs 2010, 8  
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9.0 mg DA kg
−1 bw from 20–30 minutes after i.p. injection. These signs, swimming in a circle, in a 
spiral, or upside down, were reversed after 24 hours of toxin exposure in the surviving individuals. The 
alterations in swimming behavior occurred in the following sequence. At first, the fish remained near 
the  bottom  of  the  aquarium,  to  one  side,  but  were  incapable  of  staying  in  the  expected  position. 
Subsequently, the individuals became distributed uniformly in the aquarium and showed severe circle 
swimming behavior, during which the fish were strongly impelled by the caudal fin. Finally, the fish 
remained near the surface of the aquarium, upside down, floating or slightly impelled by the pectoral 
fins. Moreover, an increase in the reactivity of S. aurata to various stimuli, visual and auditory, was 
observed.  Surviving  animals  were  monitored  over  a  four  week  period  and  all  showed  signs  of 
complete recovery. 
3.2. Light microscopy and immunohistochemistry 
Light microscopy studies revealed no major differences between the analyzed organs of the controls 
and those of the individuals exposed to DA. 
Figure  1.  Brain  sections  of  S.  aurata  showing  positive  immunoreactivity  to  the 
monoclonal antibody MAB379, which recognizes KA-type glutamate receptors (GluR5, 6, 
and 7): (1) Cerebellar cortex comprising the granular layer (g), Purkinje cell layer (P) and 
molecular  layer  (m).  The  cerebellar  glomeruli  (arrowheads)  and  Purkinje  cell  bodies 
(arrows) showed strong immunoreactivity; (2) Diencephalon comprising neuropil (n) and 
immunoreactive neuron cell bodies (arrowheads); (3) Myelencephalon comprising neuropil 
(n),  glial  cells  (arrows),  and  neurons  with  peripherial  Nissl  bodies  showing  strong 
immunoreactivity  (arrowheads);  (4)  Mesencephalon  showing  a  layer  with  small 
immunoreactive neurons (arrows) in the stratum periventricularis (sp).  
 Mar. Drugs 2010, 8  
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The monoclonal antibody MAB379, was used for immunohistochemistry of brain sections obtained 
from  fish  injected  with  PBS  alone.  Immunopositivity  for  MAB379  was  observed  with  different 
intensities (Figure 1). The negative controls showed no immunostaining. The Purkinje cell bodies, 
which are present in the cerebellar cortex, showed strong immunoreactivity, whereas the cerebellar 
glomeruli, which are located in the granular layer, showed moderate immunoreactivity (Figure 1-1). 
Several  immunoreactive  neuron  cell  bodies  were  identified  in  the  diencephalon  (Figure  1-2).  The 
neuropil,  which  is  a  dense  intricate  felt  work  of  interwoven  fine  glial  processes,  fibrils,  synaptic 
terminals, axons, and dendrites that is interspersed among the bodies of the nerve cells and of the glial 
cells,  was  found  to  be  immunonegative.  Moreover,  in  the  myelencephalon  (Figure  1-3),  strong 
immunoreactivity was observed in neurons that contained peripheral Nissl bodies, which are known to 
correspond  to  ribosomes  in  large  aggregates  and  rough  endoplasmic  reticulum.  Furthermore,  in 
mesencephalon, a layer in the stratum periventricularis that corresponded to small neurons was found 
to show a moderate positive staining (Figure 1-4). 
3.3. DA levels in the brain and liver 
The mean (± SD) concentrations of DA that were detected by HPLC-UV in extracts of the brain of 
S. aurata after exposure by i.p. injection to 9.0 mg DA kg
−1 bw were 0.61 ±  0.01, 0.96 ±  0.00, and 
0.36 ±  0.01 mg DA kg
−1 tissue at 1, 2, and 4 hours, respectively (Figure 2). 
The mean (± SD) concentrations of DA in extracts of liver from S. aurata after 1 and 2 hours of 
exposure were 2.45 ±  0.02 and 4.59 ±  0.03 mg DA kg
−1 tissue, respectively (Figure 2). The DA 
content  in  liver  extracts  after  4  hours  of  exposure  was  not  evaluated,  due  to  the  presence  of  an 
unknown  compound  after  extraction  that  had  the  same  retention  time  and  polarity  as  DA.  This 
compound was not found in any of the fish that were exposed to PBS alone. 
Figure  2.  Domoic  acid  (DA)  content  (mg  DA  kg
−1)  in  brain  and  liver  extracts  from 
S. aurata after i.p. injection of 9 mg DA kg
−1 bw. * No evaluation possible due to coelution; 
Values of DA content represent the average ±  SD from two replicate treatments. 
 Mar. Drugs 2010, 8  
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4. Discussion 
In  this  study,  DA-induced  neurotoxicity  in  fish  was  assessed  with  respect  to  mortality,  the 
occurrence of neurotoxic signs, and by observation using light microscopy. Furthermore, the amount 
of DA that was present in liver and brain extracts from S. aurata was quantified.  
The structural  similarity of DA to  glutamic  acid and, in  particular, KA,  suggests that DA  can 
activate the KA and AMPA subtypes of glutamate receptor [23]. However, the mechanism of neuronal 
stimulation in response to DA has not been well clarified. Studies in primary cortical cultures have 
shown that DA acts via high affinity binding to AMPA- and KA-sensitive glutamate receptors to 
produce excitotoxic cell death [24]. The initial cause of excitotoxicity is an increased concentration of 
extracellular glutamate, which results in over-activation of local ionotropic glutamate receptors. This 
leads  to  an  influx  of  Ca
2+,  which  results  in  a  failure  of  the  cell  to  maintain  intracellular  ion 
homeostasis, and this in turn triggers cell death [25]. In addition, cytosolic Ca
2+ levels have been 
reported to increase in hippocampus pyramidal neurons after exposure to DA [26]. DA has also been 
shown to induce excitation in cultured rat hippocampal neurons [27].  
In this study, we did not find any major morphological changes that were induced by a single dose 
of DA. In contrast, Tryphonas and Iverson [28] reported that the i.p. administration of a single dose of 
4 mg DA kg
−1 to rats resulted in acute damage. Typical vacuolation of neuropili, hydropic cytoplasmic 
swelling of resident astrocytes and nerve cell hyperchromasia and shrinkage occurred. DA-induced 
neuronal cell loss (>80%) as well as the loss of neuronal cell bodies and degeneration of dendrites, in 
mice have been reported [24]. On the other hand, vacuolation of the neutropil and hypercromasia in the 
hippocampus, hypothalamus, area prostema, and the inner layers of the retina were noted post-mortem 
in primates that had been given DA at 0.5 mg DA kg
−1intravenously or 4 mg DA kg
−1 i.p. [29].  
The fact that we did not observe permanent tissue damage in S. aurata by light microscopy, and that 
the toxic signs observed after exposure to DA were reversible, suggest that neuronal recovery occurred 
in the affected individuals. In our study, typical neurotoxic signs were observed in all individuals 
exposed to 9.0 mg DA kg
−1 after 20–30 minutes. The variety of toxic signs observed in S. aurata that 
were exposed to a single dose of 9.0 mg DA kg
−1, for example swimming in a circle, in a spiral, or 
upside down, were consistent with those reported previously for other fish genera after being injected 
with DA i.p. [15,17]. The systemic administration of DA to rats at a single dose of 1.3 mg kg
−1 also 
caused  a  variety  of  toxic  signs,  which  included  stereotypic  hind  limb  behaviors,  scratching,  and 
death [30]. Similarly to our study, these authors also reported a significant exaggerated auditory startle 
in rats exposed to DA.  
Likewise, a study on the behavioral responses of mice after the administration of mussel extract i.p., 
observed a variety of responses, which included hypo activity, sedation, rigidity, scratching, head 
weaving, loss of postural control, tremors, convulsions, and death [23]. Similar neurotoxic effects to 
those  observed  in  rodents  have  also  been  reported  in  non-human  primates,  but  are  dominated  by 
gagging and vomiting. Cynomolgus monkeys that were exposed to a single dose of 4 mg DA kg
−1 
showed severe vomiting, hypothermia, acute pulmonary edema, and death within four hours [29].  
The time course of observation of the neurotoxic signs was relevant for the interpretation of other 
data  collected,  such  as  the  concentration  of  DA  in  the  tissue  extracts.  At  two  hours  after  i.p. 
administration, the concentration of DA in the brain and liver extracts had increased, which indicated Mar. Drugs 2010, 8  
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the bioavailability of DA in the systemic circulation. Conversely, at four hours, the amount of toxin 
detected in the brain had decreased again, to a value that was lower than that detected at one hour after 
exposure.  These  data  are  in  agreement  with  the  observed  time  frame  for  the  recovery  of  normal 
behavior for all DA treatments, i.e., after four hours of exposure, and also with findings published in 
the literature. Lefebvre et al. [17] indicated that DA is present in fish for only a short time period. The 
amount of DA that we detected in the liver after one or two hours of exposure indicated that the toxin 
was absorbed well from the coelomic cavity into the blood through capillaries, as had been expected 
due to the high solubility of DA in the water. The degree of toxicity exhibited, and the amount of DA 
detected in the tissues that were analyzed, also indicated that most of the toxin entered the systemic 
circulation  directly. Moreover, the concentration of DA in  extracts  from  the brain, showed that a 
portion  of  the  DA  that  was  administered  i.p.,  migrate  to  the  brain  causing  the  above  mentioned 
neurotoxic signs. 
Very limited data is available in the literature regarding the absorption, distribution, metabolism, 
and excretion of DA in non-mammal models. Truelove et al. (1996) reported that in rats to which 
5 mg DA kg
−1 bw was administered by oral gavage (o.g.), only 2% of the dose was excreted in the 
urine [31,32].  
Data from neurotoxicity assays revealed that the susceptibility of S. aurata to i.p. exposure to DA 
was similar to that of other fish, such as anchovies, coho salmon, and Atlantic salmon. The suggested 
lower susceptibility to DA toxic effects shown in the individuals that survived at 9.0 mg DA kg
−1 
treatment, might be in accordance with the absence of neurotoxic effects in leopard sharks, that have 
been exposed to concentrations of DA that were three times higher than those used in this study [14]. 
An overview of different factors that might modify cell injury associated to DA excitotoxicity, can be 
found  in  literature  [20].  Although  the  surviving  individuals  in  our  study  appeared  to  recover 
completely with no apparent lesions, more detailed studies are required in order to assess the effects of 
DA on brain metabolic activity or ultrastructural features. 
In this study, we detected positive immunoreactivity to the monoclonal antibody MAB379, which 
recognizes the KA-type glutamate receptors (GluR5, 6, 7) in the brain of S. aurata, specifically in the 
cerebellar cortex, diencephalon, myelencephalon, and mesencephalon. This indicates that these regions 
of the brain  contain at  least  one of the KA-type glutamate receptors,  which are  a target  for  DA. 
Immunohistochemistry  studies  performed  in  leopard  sharks  identified  similar  patterns  of 
immunoreactivity in the same regions of the brain [14]. 
In nature, the exposure of S. aurata to sublethal concentrations of DA via the trophic food chain 
might compromise behaviors such as the capture of prey, predator avoidance, courtship, and mating. 
Nevertheless, the studies have shown that DA toxicity is much higher by i.p. injection than by oral 
intake on other fish species [17]. 
Taken together, the immunohistochemical studies and the behavioral observations enable a putative 
association between the two sets of findings to be established. The cerebellum, which showed strong 
immunoreactivity for the MAB379 antibody, is known to be involved in the maintenance of positional 
equilibrium,  which  was  clearly  affected  in  the  S.  aurata  exposed  to  DA.  In  particular,  the  fish 
metencephalon is involved in processing information that is important for maintaining the positional 
equilibrium  of  the  organism  and  for  the  refinement  of  motor  action. These  functions  were  clearly 
affected  in  individuals  exposed  to  9.0  mg  DA  kg
−1  bw.  Moreover,  the  myelencephalon  operates Mar. Drugs 2010, 8  
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primarily at the reflex level, given that it contains the centre for visceral, auditory, and proprioreceptive 
reflexes [33]. The myelencephalon is also the area associated with sound reception and integrates the 
taste  and  auditory  senses  [34].  These  functions  were  affected  in  S.  aurata  that  were  exposed  to 
9.0 mg DA kg
−1 bw, as revealed by the increased reactivity of individuals to visual and auditory stimuli. 
In conclusion, the data obtained in this study indicate that a single, sublethal dose of DA does not 
seem to result in any acute damage to the brain tissue of the gilthead seabream S. aurata. Similarly, the 
behavioral changes that occurred after the injection i.p. of a single, sublethal dose of DA were found to 
be reversed fully after 24 hours.  
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